Preferred Label : Cisplatin/Fluorouracil/Pembrolizumab/Trastuzumab Regimen;
NCIt synonyms : Cisplatin/Fluorouracil/Pembrolizumab/Trastuzumab; Cisplatin-Fluorouracil-Pembrolizumab-Trastuzumab; Fluorouracil/Cisplatin/Pembrolizumab/Trastuzumab; Cisplatin/Fluorouracil/Keytruda/Herceptin Regimen;
NCIt related terms : Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab-dttb; Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab-qyyp; Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab-herw; Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab-pkrb; Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab-dkst; Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab; Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab-zerc; Cisplatin and Fluorouracil (CF), Pembrolizumab, Trastuzumab-anns;
NCIt definition : A regimen consisting of cisplatin, fluorouracil, pembrolizumab and trastuzumab that
can be used in the treatment of esophageal and esophagogastric junction, and gastric
cancers.;
NCI Metathesaurus CUI : CL1926251;
Codes from synonyms : 121882; 135074; 135069; 135071; 135073; 135068; 135070; 135072;
Origin ID : C203959;
UMLS CUI : C5909522;
Semantic type(s)
chemotherapy_regimen_has_component
concept_is_in_subset